Triple
T22492456
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Amphotericin B |
E556051
|
entity |
| Predicate | isListedOn |
P1278
|
FINISHED |
| Object | World Health Organization Model List of Essential Medicines |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: World Health Organization Model List of Essential Medicines | Statement: [Amphotericin B, isListedOn, World Health Organization Model List of Essential Medicines]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: World Health Organization Model List of Essential Medicines Context triple: [Amphotericin B, isListedOn, World Health Organization Model List of Essential Medicines]
-
A.
World Health Organization Model List of Essential Medicines
chosen
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
B.
WHO Expert Committee on Selection and Use of Essential Medicines
The WHO Expert Committee on Selection and Use of Essential Medicines is a specialized World Health Organization body that evaluates evidence and advises which medicines should be prioritized globally for inclusion on the Model List of Essential Medicines.
-
C.
WHO Collaborating Centre for Drug Statistics Methodology
The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
-
D.
Community code for medicinal products for human use
The Community code for medicinal products for human use is a comprehensive European Union regulatory framework that harmonizes the authorization, supervision, and distribution of human medicines across EU member states.
-
E.
Doha Declaration on the TRIPS Agreement and Public Health
The Doha Declaration on the TRIPS Agreement and Public Health is a 2001 WTO ministerial statement affirming that intellectual property rules should not prevent members from protecting public health and ensuring access to affordable medicines.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e5445bc8190b6a9481926db3355 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f15cb01b3481908a9143503b75167f |
completed | April 29, 2026, 1:19 a.m. |
Created at: April 16, 2026, 8:49 p.m.